Zhuang et al. [16] uncovered a similar trend in 16 renal carcinoma tumors heterozygous for a MET mutation, and a study of 26 mouse skin tumors found 16 with a mutant HRAS homolog allele amplified but none with the wild-type allele amplified [15]. The gene discussed is HRAS; the disease is skin neoplasm.